- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02988609
Concussion in Rugby Players: a Pilot Study of Neural Recovery Using fMRI (RugbyCom)
January 2, 2024 updated by: University Hospital, Toulouse
Concussion in Rugby Players: a Pilot Study of Neural Recovery Using Functional Magnetic Resonance Imaging (fMRI)
This study assess the putative persistence of neural damage using resting state fMRI after concussion in rugby player once they have clinically recovered.
The hypothesis is that despite a clinical recovery (absence of symptoms; neurological and neuropsychological examination returned to normal) connectivity map obtained using resting state fMRI are significantly different from a group of control subjects.
Study Overview
Detailed Description
Resting state fMRI has shown to be a sensitive tool to assess neural damage after concussion.
It seems more sensible than structural MRI including DTI. the study goal will be to assess rugby players using fMRI at 3 different times after concussion: just after concussion (V1), once players have clinically recovered (V2) and 3 months after V2 (V3).
The study would specifically like to challenge clinical examination supposed to be normal at V2 to connectivity maps using resting state fMRI preformed at the same time.
fMRI performed at V1 and V3 will serve as comparators (respectively very altered at V1 and back to normal at V3).
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David BRAUGE, MD
- Phone Number: 33561777686
- Email: brauge.d@chu-toulouse.fr
Study Locations
-
-
-
Toulouse, France, 31059
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- no neurological or psychiatric disease
- recent history of concussion (<3 months) according to the Rugby French Federation criteria.
Exclusion Criteria:
- Inability to be assessed by MRI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Concussion Group
Players with a recent (<72 hours) history of concussion will be assessed 3 times.
just after concussion, after disappearance of clinical symptoms and 3 months after the previous visit.
During each visit, participant will undergo a neurological and a neuropsychological assessment and a structural and resting state fMRI.
|
fMRI at 3 different times after concussion: just after concussion (V1), once players have clinically recovered (V2) and 3 months after V2 (V3).
|
Active Comparator: Control Group
a control group with no history of concussion will be the comparator.
Participants will be assessed 3 times.
Visits will be the same for the control group and duration between visits in this group will be matched to the concussion group.
During each visit, participant will undergo a neurological and a neuropsychological assessment and a structural and resting state fMRI.
|
fMRI at 3 different times after concussion: just after concussion (V1), once players have clinically recovered (V2) and 3 months after V2 (V3).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference of connectivity maps between the players with concussion and the group control
Time Frame: up to 1 month
|
connectivity maps obtained during a 10 minutes resting state fMRI at V2
|
up to 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference of connectivity maps between the players with concussion and the group control
Time Frame: up to 3 months
|
Connectivity maps obtained during a 10 minutes resting state fMRI at V1 and V3
|
up to 3 months
|
neuropsychological questionnaire
Time Frame: up to 3 months
|
Scores obtained the neuropsychological assessment.
Memory, attention and executive functions will be assessed using validated tools.
|
up to 3 months
|
neurophysiological data
Time Frame: up to 3 months
|
Structural imaging data (DTI)
|
up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David BRAUGE, MD, U H Toulouse
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2016
Primary Completion (Actual)
August 1, 2022
Study Completion (Actual)
October 10, 2022
Study Registration Dates
First Submitted
May 13, 2016
First Submitted That Met QC Criteria
December 8, 2016
First Posted (Estimated)
December 9, 2016
Study Record Updates
Last Update Posted (Estimated)
January 3, 2024
Last Update Submitted That Met QC Criteria
January 2, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- RC31/15/7730
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Concussion
-
Sync-Think, Inc.CompletedBrain Injuries | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion; Eye | Concussion, CerebralUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
Spaulding Rehabilitation HospitalTerminated
-
Panam ClinicCompleted
-
University of PennsylvaniaUniversity of Oklahoma; Carnegie Mellon UniversityWithdrawnConcussion
-
Oregon Center for Applied Science, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Thomas Jefferson UniversityRothman Institute OrthopaedicsTerminated
-
University of PittsburghWithdrawnConcussionUnited States
Clinical Trials on fMRI
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterWithdrawnBrain TumorsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Brighton & Sussex Medical SchoolRecruitingDepressionUnited Kingdom
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Hospices Civils de LyonUniversity of KonstanzCompleted
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States